Webinar: Thursday, 24 August 2023, 7:00 PM

Abnormal glucose tolerance and cardiovascular risk

Abnormal-glucose tolerance is due to an imbalance between β-cell function and insulin resistance and is a major risk factor in cardiovascular disease. In sub-Saharan Africa, β-cell failure is emerging as an important cause of abnormal glucose tolerance. Join NWU's Dr Annemarie Wentzel for an in-depth, CPD-accredited discussion on this crucial part of the sub-Saharan diabetes/CV picture and its implications.

Presented by
Conrad Strydom

Conrad Strydom

  • Editor: Medical Academic
Dr Annemarie Wentzel

Dr Annemarie Wentzel

  • Physiology Researcher
Dr Wentzel is a senior lecturer and researcher in Physiology at North-West University. She focuses on exploring the physiological mechanisms activated during acute and chronic cardiometabolic, hydrodynamic and psychological stress responses within healthy and at-risk populations. Ultimately, she wants to investigate how these mechanisms may differ in, and translate to specific health outcomes (specifically diabetes, stroke and coronary artery disease). She is a member of the American Heart Association (AHA), American Autonomic Society (AAS), South African Heart Association (SAHA) and Physiological Society of South Africa (PSSA).

881 professionals have already registered.

Days
:
Hours
:
Minutes
:
Seconds

Webinar Registration

By registering for this webinar, you agree to our Terms & Conditions.

New Media, a division of Media24 (PTY) Ltd., abides to all data and privacy requirements. To find out more about our Privacy Policy you can find it here: www.media24.com/group-privacy-portal.

Please Note: The names, surnames, email addresses and duration of attendance of all webinar participants will be shared for statistical purposes only, with the sponsor of this webinar. No delegate will be contacted by the sponsor with marketing or sales offers, and your information will not be shared with any third-parties.

Should you wish to receive further information on the webinar topic from our sponsor, please opt in above.